SCHEMBL24845796

SCHEMBL24845796

Clc1c2cccc1n(-c1ccccc1)c1ccc(cc1)n(-c1ccccc1)c1cccc(c1Cl)n(-c1ccccc1)c1ccc(cc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 2/20 0.46
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 1/20 0.37
HTT P42858 1/20 0.37
GSK3A P49840 3/20 0.35
GSK3B P49841 3/20 0.35
GAA P10253 2/20 0.35
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
PGR P06401 2/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
DCTPP1 Q9H773 1/20 0.34
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2390706 0.75 KDM4E (0.50) L3MBTL1KDM4EATMMAPK1HSD17B10
SCHEMBL23876400 0.72 MAPK1 (0.42) L3MBTL1KDM4EATMMAPK1HTT
SCHEMBL13589329 0.70 KDM4E (0.41) L3MBTL1KDM4EATMMAPK1GSK3A
SCHEMBL10025810 0.68 KDM4E (0.50) L3MBTL1KDM4EATMMAPK1HSD17B10
SCHEMBL14867678 0.68 L3MBTL1 (0.50) L3MBTL1KDM4EATMMAPK1HSD17B10
SCHEMBL22649021 0.68 L3MBTL1 (0.61) L3MBTL1KDM4EATMMAPK1HTT
SCHEMBL20276611 0.67 L3MBTL1 (0.48) L3MBTL1KDM4EATMMAPK1HSD17B10
SCHEMBL22247786 0.67 L3MBTL1 (0.59) L3MBTL1KDM4EATMMAPK1HTT
SCHEMBL22248344 0.65 KDM4E (0.57) L3MBTL1KDM4EATMMAPK1HSD17B10
SCHEMBL22067828 0.65 HSD17B10 (0.38) L3MBTL1KDM4EATMMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002416-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002416-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES GPX1, L1CAM, TMEM109 L3MBTL1 2636/4885KDM4E 2832/4885ATM 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.